Mitsui Chemicals Geçmiş Kazanç Performansı
Geçmiş kriter kontrolleri 2/6
Mitsui Chemicals şirketinin kazançları yıllık ortalama -28.5% oranında azalırken, Chemicals sektörünün kazançları yıllık 6.1% oranında artan oldu. Gelirler yıllık ortalama 4% oranında artan oldu. Mitsui Chemicals şirketinin öz sermaye getirisi 4.7% olup, net marjı 2.1% dir.
Anahtar bilgiler
-28.45%
Kazanç büyüme oranı
-27.73%
EPS büyüme oranı
| Chemicals Sektör Büyümesi | 6.58% |
| Gelir büyüme oranı | 4.04% |
| Özkaynak getirisi | 4.74% |
| Net Marj | 2.06% |
| Sonraki Kazanç Güncellemesi | 05 Aug 2026 |
Yakın geçmiş performans güncellemeleri
Recent updates
Anlatı Güncellemesi • Jul 15
4183: U.S. Oral Care Hub And Richer Multiple Will Limit Future Returns
Analysts have revised their 12 month price target for Mitsui Chemicals from ¥1,550 to ¥1,790, citing updated assumptions for slightly higher revenue growth, improved profit margins, and a modest increase in the future P/E multiple. What’s in the News for Mitsui Chemicals Mitsui Chemicals is shifting its global oral care headquarters to the U.S., aiming to make oral care a core growth pillar and position itself more as a solutions provider for dental patients and professionals.
Anlatı Güncellemesi • Jul 01
4183: Buybacks And Treasury Share Disposal Plans Will Shape A Balanced Outlook
The analyst price target for Mitsui Chemicals has been revised from ¥2,251.67 to ¥2,350.00. Analysts cited updated assumptions around revenue growth, profit margin and future P/E as the basis for the change.Anlatı Güncellemesi • Jun 17
4183: Softer Margins And Oral Care Expansion Will Restrain Future Share Returns
Analysts have maintained their fair value estimate for Mitsui Chemicals at ¥1,550, while adjusting key assumptions including a lower discount rate, slightly softer revenue growth and profit margin expectations, and a higher future P/E multiple to reflect the current research backdrop. What’s in the News for Mitsui Chemicals Mitsui Chemicals’ U.S. subsidiary agreed to acquire Ultradent Products to expand the group’s global oral care business, combining Ultradent’s U.S. presence with Mitsui’s Kulzer operations in the EMEA region.
Anlatı Güncellemesi • Jun 03
4183: Share Buybacks Will Support Long Term Upside As Earnings Multiple Re-Rates
Analysts are keeping their ¥3,000 price target for Mitsui Chemicals unchanged. They point to small model tweaks in the discount rate, revenue growth, profit margin, and future P/E assumptions rather than a shift in the overall outlook.Anlatı Güncellemesi • May 15
4183: Share Buybacks Will Support Long Term Upside As Earnings Multiple Re-Rates
Analysts have kept their fair value estimate for Mitsui Chemicals steady at ¥3,000 per share. The updated price target reflects slightly adjusted assumptions for discount rate, revenue growth, profit margin and future P/E rather than a major shift in their overall view of the stock.Anlatı Güncellemesi • Apr 26
4183: Weaker Earnings Outlook And Margin Pressure Will Weigh On Future Returns
Analysts have raised Mitsui Chemicals' fair value estimate from ¥1,500 to ¥1,550, citing updated assumptions that combine a slightly higher discount rate and a modestly lower profit margin with a materially higher revenue growth outlook and a marginally lower future P/E multiple. What's in the News Mitsui Chemicals has launched a share repurchase program of up to 18,400,000 shares, or 4.89% of its share capital, for ¥30,000m, with plans to cancel treasury shares after repurchase and a program period running until July 31, 2026 (Key Developments).Anlatı Güncellemesi • Apr 12
4183: Share Buybacks Will Support Long Term Upside Despite Near Term Margin Pressure
Analysts have kept the fair value estimate for Mitsui Chemicals steady at ¥3,000 by refining assumptions on discount rate, revenue growth, profit margin, and future P/E, which together underpin the updated price target narrative. What's in the News Mitsui Chemicals has launched a share repurchase program to buy up to 18,400,000 shares, around 4.89% of its share capital, for ¥30,000m, with plans to cancel the repurchased shares and run the program through July 31, 2026 (Board meeting and buyback transaction announcements, February 5, 2026).Anlatı Güncellemesi • Mar 28
4183: Renewable Plastics And Buybacks Will Support Long Term Share Upside
Analysts have maintained their ¥3,000 price target for Mitsui Chemicals, noting that only minor adjustments to assumptions such as discount rate, revenue growth, profit margin, and future P/E have been made, and these do not materially change their overall view of the shares. What's in the News Mitsui Chemicals is part of a 14 company global supply chain across five countries and regions to produce renewable plastics for Sony's high performance audio visual products, with a focus on tracking and documenting GHG emissions across the chain and supporting Sony's move away from virgin fossil based plastics (Key Developments).Anlatı Güncellemesi • Mar 14
4183: Renewable Plastics Supply Chain Will Reshape Long-Term Earnings Profile
Analysts have reset their price target on Mitsui Chemicals from ¥5,400 to ¥3,000, reflecting updated assumptions for slightly lower discount rates, as well as revised expectations for revenue growth, profit margins, and future P/E levels. What's in the News Mitsui Chemicals joined thirteen other companies across five countries to build what is described as the world's first global supply chain for renewable plastics for use in Sony's high performance audio visual products, allowing tracking of greenhouse gas emissions across the chain and supporting Sony's goal to reduce virgin fossil based plastics (Key Developments).Analiz Makalesi • Feb 13
Mitsui Chemicals' (TSE:4183) Conservative Accounting Might Explain Soft Earnings
Shareholders appeared unconcerned with Mitsui Chemicals, Inc.'s ( TSE:4183 ) lackluster earnings report last week. Our...Analiz Makalesi • Feb 08
Earnings Miss: Mitsui Chemicals, Inc. Missed EPS By 63% And Analysts Are Revising Their Forecasts
As you might know, Mitsui Chemicals, Inc. ( TSE:4183 ) last week released its latest quarterly, and things did not turn...Analiz Makalesi • Feb 05
Why Investors Shouldn't Be Surprised By Mitsui Chemicals, Inc.'s (TSE:4183) P/E
With a price-to-earnings (or "P/E") ratio of 47.9x Mitsui Chemicals, Inc. ( TSE:4183 ) may be sending very bearish...Anlatı Güncellemesi • Feb 05
4183: Decarbonization Investments And Stock Split Plans Will Shape A Balanced Outlook
Analysts have lifted their fair value estimate for Mitsui Chemicals from ¥2,170.83 to ¥2,251.67, citing slightly lower discount rate assumptions, minor adjustments to long term revenue growth and profit margin forecasts, and a modestly higher future P/E multiple. What's in the News Mitsui Chemicals, Asahi Kasei, and Mitsubishi Chemical were selected for Japan's Fiscal 2025 HtA Support Program to support decarbonization and production conversion at two ethylene facilities in western Japan, with a stated investment scale of ¥21.2b and a maximum subsidy application amount of ¥10.4b (HtA Support Program announcement).Anlatı Güncellemesi • Jan 22
4183: Stock Split Plans And Updated Guidance Will Shape A Balanced Outlook
Analysts have revised their price target on Mitsui Chemicals from ¥4,250.91 to ¥2,170.83, citing updated assumptions around slightly lower discount rates, adjusted revenue growth and profit margin expectations, and a modestly different future P/E multiple. What's in the News Mitsui Chemicals has scheduled a board meeting for November 11, 2025, with an agenda that includes discussing a potential stock split (Key Developments).Anlatı Güncellemesi • Jan 07
4183: Future Stock Split And Margin Pressure Will Weigh On Returns
Analysts have adjusted their price target for Mitsui Chemicals from ¥3,000 to ¥1,500, citing updated assumptions for revenue growth, profit margins, and future P/E multiples. What's in the News Mitsui Chemicals scheduled a board meeting for November 11, 2025 to discuss a potential stock split (Key Developments).Analiz Makalesi • Dec 03
Mitsui Chemicals (TSE:4183) Has Announced A Dividend Of ¥75.00
Mitsui Chemicals, Inc. ( TSE:4183 ) will pay a dividend of ¥75.00 on the 25th of June. The dividend yield will be 3.9...Analiz Makalesi • Oct 23
Investors Appear Satisfied With Mitsui Chemicals, Inc.'s (TSE:4183) Prospects
When close to half the companies in Japan have price-to-earnings ratios (or "P/E's") below 14x, you may consider Mitsui...Analiz Makalesi • Sep 22
Mitsui Chemicals' (TSE:4183) Dividend Will Be ¥75.00
Mitsui Chemicals, Inc. ( TSE:4183 ) has announced that it will pay a dividend of ¥75.00 per share on the 3rd of...Anlatı Güncellemesi • Sep 21
Specialty Chemicals Restructuring Will Unlock Sustainable Market Potential
The upward revision in Mitsui Chemicals’ price target is underpinned by a marginal improvement in consensus revenue growth forecasts and a slightly higher expected future P/E, resulting in the fair value estimate increasing from ¥4151 to ¥4251. What's in the News Revised H1 2025 earnings guidance: sales revenue JPY 818.0 billion, operating income JPY 31.0 billion, net income JPY 7.5 billion, basic EPS JPY 40.03.Analiz Makalesi • Sep 08
Mitsui Chemicals (TSE:4183) Has Announced A Dividend Of ¥75.00
The board of Mitsui Chemicals, Inc. ( TSE:4183 ) has announced that it will pay a dividend of ¥75.00 per share on the...Anlatı Güncellemesi • Sep 06
Specialty Chemicals Restructuring Will Unlock Sustainable Market Potential
With Mitsui Chemicals’ consensus analyst price target and key valuation metrics such as the discount rate and future P/E ratio all remaining effectively unchanged, analysts see no material change in fair value, maintaining the target at ¥4151. What's in the News Revised first-half FY2025 guidance: sales revenue expected at JPY 818.0 billion, operating income JPY 31.0 billion, net income JPY 7.5 billion, and basic EPS JPY 40.03.Analiz Makalesi • Aug 25
Mitsui Chemicals (TSE:4183) Has Affirmed Its Dividend Of ¥75.00
Mitsui Chemicals, Inc. ( TSE:4183 ) has announced that it will pay a dividend of ¥75.00 per share on the 3rd of...Analiz Makalesi • Aug 14
Mitsui Chemicals' (TSE:4183) Soft Earnings Don't Show The Whole Picture
TSE:4183 1 Year Share Price vs Fair Value Explore Mitsui Chemicals's Fair Values from the Community and select yours...Analiz Makalesi • Aug 11
Mitsui Chemicals (TSE:4183) Will Pay A Dividend Of ¥75.00
The board of Mitsui Chemicals, Inc. ( TSE:4183 ) has announced that it will pay a dividend on the 3rd of December, with...Analiz Makalesi • Aug 10
Mitsui Chemicals, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
TSE:4183 1 Year Share Price vs Fair Value Explore Mitsui Chemicals's Fair Values from the Community and select yours...
Yeni Anlatı • Jan 05
Yen Depreciation And Specialty Chemicals Surge Will Propel Operating Income And Revenue Growth
Yen depreciation and improved trade terms are expected to boost operating income in specialty chemicals, positively impacting revenue.Gelir ve Gider Dağılımı
Gelir ve Gider Dağılımı
Mitsui Chemicals nasıl para kazanır ve harcar. LTM bazında en son bildirilen kazançlara dayanmaktadır.
Kazanç ve Gelir Geçmişi
| Tarih | Gelir | Kazançlar | G+A Giderleri | Ar-Ge Giderleri |
|---|---|---|---|---|
| 31 Mar 26 | 1,668,754 | 34,378 | 294,540 | 0 |
| 31 Dec 25 | 1,689,039 | 17,112 | 228,965 | 45,781 |
| 30 Sep 25 | 1,732,403 | 17,856 | 230,395 | 45,781 |
| 30 Jun 25 | 1,775,043 | 15,082 | 229,862 | 45,781 |
| 31 Mar 25 | 1,809,164 | 32,242 | 295,352 | 0 |
| 31 Dec 24 | 1,814,049 | 50,449 | 236,924 | 44,695 |
| 30 Sep 24 | 1,816,439 | 51,541 | 227,324 | 44,695 |
| 30 Jun 24 | 1,791,289 | 58,297 | 227,725 | 44,695 |
| 31 Mar 24 | 1,749,743 | 49,999 | 223,538 | 44,695 |
| 31 Dec 23 | 1,725,166 | 55,251 | 228,746 | 42,954 |
| 30 Sep 23 | 1,752,125 | 59,270 | 234,856 | 42,954 |
| 30 Jun 23 | 1,811,359 | 64,535 | 233,541 | 42,954 |
| 31 Mar 23 | 1,879,547 | 82,936 | 233,508 | 42,954 |
| 31 Dec 22 | 1,876,520 | 74,869 | 235,654 | 38,124 |
| 30 Sep 22 | 1,820,230 | 80,403 | 224,314 | 38,124 |
| 30 Jun 22 | 1,718,210 | 95,358 | 209,133 | 38,124 |
| 31 Mar 22 | 1,612,688 | 109,990 | 195,593 | 38,124 |
| 31 Dec 21 | 1,519,376 | 124,939 | 185,999 | 33,802 |
| 30 Sep 21 | 1,418,281 | 122,211 | 179,712 | 33,802 |
| 30 Jun 21 | 1,327,832 | 102,815 | 175,455 | 33,802 |
| 31 Mar 21 | 1,211,725 | 57,873 | 168,245 | 33,802 |
| 31 Dec 20 | 1,197,363 | 43,821 | 175,046 | 36,368 |
| 30 Sep 20 | 1,201,052 | 35,788 | 177,964 | 36,368 |
| 30 Jun 20 | 1,250,675 | 23,105 | 183,474 | 36,368 |
| 31 Mar 20 | 1,338,987 | 37,944 | 191,850 | 36,368 |
| 31 Dec 19 | 1,367,168 | 45,327 | 189,872 | 35,796 |
| 30 Sep 19 | 1,436,908 | 46,113 | 190,328 | 35,796 |
| 30 Jun 19 | 1,469,442 | 65,163 | 188,872 | 35,796 |
| 31 Mar 19 | 1,482,909 | 76,115 | 187,109 | 35,796 |
| 31 Dec 18 | 1,483,490 | 68,628 | 187,856 | 33,377 |
| 30 Sep 18 | 1,428,586 | 75,161 | 183,445 | 33,377 |
| 30 Jun 18 | 1,375,771 | 72,350 | 178,310 | 33,377 |
| 31 Mar 18 | 1,328,526 | 71,585 | 172,498 | 33,377 |
| 31 Dec 17 | 1,302,040 | 75,678 | 172,056 | 30,777 |
| 30 Sep 17 | 1,264,410 | 75,256 | 167,823 | 30,777 |
| 30 Jun 17 | 1,227,608 | 71,343 | 163,602 | 30,777 |
| 31 Mar 17 | 1,212,282 | 64,839 | 161,458 | 30,777 |
| 31 Dec 16 | 1,182,185 | 39,377 | 159,186 | 31,493 |
| 30 Sep 16 | 1,203,978 | 22,269 | 160,214 | 31,493 |
| 30 Jun 16 | 1,258,485 | 22,353 | 162,382 | 31,493 |
| 31 Mar 16 | 1,343,898 | 22,963 | 172,028 | 31,493 |
| 31 Dec 15 | 1,416,701 | 31,842 | 173,540 | 32,396 |
| 30 Sep 15 | 1,482,764 | 38,358 | 174,235 | 32,396 |
Kaliteli Kazançlar: 4183 büyük bir tek seferlik zarar ile ¥23.6B, 31st March, 2026 tarihine ait son 12 aylık mali sonuçları etkiliyor.
Büyüyen Kar Marjı: 4183 'nin mevcut net kar marjları (2.1%) geçen yılın (1.8%) sinden daha yüksektir.
Serbest Nakit Akışı ve Kazanç Analizi
Geçmiş Kazanç Büyüme Analizi
Kazanç Eğilimi: 4183 şirketinin kazançları son 5 yılda yılda 28.5% oranında azaldı.
Büyüme Hızlandırma: 4183 'un son bir yıldaki kazanç büyümesi ( 6.6% ) 5 yıllık ortalamasını (yıllık -28.5% ) aşıyor.
Kazançlar vs. Sektör: 4183 geçen yılki kazanç büyümesi ( 6.6% ) Chemicals sektörünün 12.8% performansını geride bırakmadı.
Özkaynak Getirisi
Yüksek ROE: 4183 'nin Özsermaye Getirisi ( 4.7% ) düşük olarak değerlendiriliyor.
Varlık Getirisi
Kullanılan Sermaye Getirisi
Geçmişte güçlü performans gösteren şirketleri keşfedin
Şirket Analizi ve Finansal Veri Durumu
| Veri | Son Güncelleme (UTC saati) |
|---|---|
| Şirket Analizi | 2026/07/28 07:57 |
| Gün Sonu Hisse Fiyatı | 2026/07/28 00:00 |
| Kazançlar | 2026/03/31 |
| Yıllık Kazançlar | 2026/03/31 |
Veri Kaynakları
Şirket analizimizde kullanılan veriler S&P Global Market Intelligence LLC'den alınmıştır. Bu raporu oluşturmak için analiz modelimizde aşağıdaki veriler kullanılmıştır. Veriler normalize edilmiştir, bu da kaynağın mevcut olmasından kaynaklanan bir gecikmeye neden olabilir.
| Paket | Veri | Zaman Çerçevesi | Örnek ABD Kaynağı * |
|---|---|---|---|
| Şirket Finansalları | 10 yıl |
| |
| Analist Konsensüs Tahminleri | +3 yıl |
|
|
| Piyasa Fiyatları | 30 yıl |
| |
| Sahiplik | 10 yıl |
| |
| Yönetim | 10 yıl |
| |
| Önemli Gelişmeler | 10 yıl |
|
* ABD menkul kıymetleri için örnek, ABD dışı için eşdeğer düzenleyici formlar ve kaynaklar kullanılmıştır.
Belirtilmediği sürece tüm finansal veriler yıllık bir döneme dayanmaktadır ancak üç ayda bir güncellenmektedir. Bu, İzleyen On İki Ay (TTM) veya Son On İki Ay (LTM) Verileri olarak bilinir. Daha fazla bilgi edinin.
Analiz Modeli ve Kar Tanesi
Bu raporu oluşturmak için kullanılan analiz modelinin ayrıntılarına Github sayfamızdan ulaşabilirsiniz; ayrıca raporlarımızı nasıl kullanacağınıza dair kılavuzlarımız ve YouTube’da eğitim videolarımız da bulunmaktadır.
Simply Wall St analiz modelini tasarlayan ve oluşturan dünya standartlarındaki ekip hakkında bilgi edinin.
Endüstri ve Sektör Metrikleri
Sektör ve bölüm metriklerimiz Simply Wall St tarafından her 6 saatte bir hesaplanmaktadır, sürecimizin ayrıntıları Github'da mevcuttur.
Analist Kaynakları
Mitsui Chemicals, Inc. 19 Bu analistlerden 12, raporumuzun girdisi olarak kullanılan gelir veya kazanç tahminlerini sunmuştur. Analistlerin gönderimleri gün boyunca güncellenmektedir.
| Analist | Kurum |
|---|---|
| Mikiya Yamada | Barclays |
| Takashi Enomoto | BofA Global Research |
| Yuta Nishiyama | Citigroup Inc |